Ohcanbohtosat - Zeev Estrov
- Čájehuvvo 1 - 20 / 137
- Sirdás čuovvovaš siidui
-
1
Chronic myelogenous leukemia: a concise update Dahkki HM Kantarjian, A B Deisseroth, Razelle Kurzrock, Zeev Estrov, Moshe Talpaz
Almmustuhtton 1993Artigo -
2
Metabolism pathways in chronic lymphocytic leukemia Dahkki Uri Rozovski, Inbal Hazan‐Halevy, Merav Barzilai, Michael J. Keating, Zeev Estrov
Almmustuhtton 2015Revisão -
3
-
4
-
5
-
6
-
7
Both Cell Fusion and Transdifferentiation Account for the Transformation of Human Peripheral Blood CD34-Positive Cells Into Cardiomyocytes In Vivo Dahkki Sui Zhang, Dachun Wang, Zeev Estrov, Sean D. Raj, James T. Willerson, Edward T.H. Yeh
Almmustuhtton 2004Artigo -
8
Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia Dahkki Steven M. Kornblau, David McCue, Neera Singh, Wenjing Chen, Zeev Estrov, Kevin R. Coombes
Almmustuhtton 2010Artigo -
9
Is acute myeloid leukemia a liquid tumor? Dahkki Maro Ohanian, Stefan Faderl, Farhad Ravandi, Naveen Pemmaraju, Guillermo Garcia‐Manero, Jorge E. Cortés, Zeev Estrov
Almmustuhtton 2013Revisão -
10
-
11
-
12
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activit... Dahkki Zeev Estrov, Razelle Kurzrock, Meir Wetzler, Hagop M. Kantarjian, Mary Blake, David Harris, JU Gutterman, Moshe Talpaz
Almmustuhtton 1991Artigo -
13
Resveratrol blocks interleukin-1β–induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloi... Dahkki Zeev Estrov, Shishir Shishodia, Stefan Faderl, David Harris, Quin Van, Hagop M. Kantarjian, Moshe Talpaz, Bharat B. Aggarwal
Almmustuhtton 2003Artigo -
14
-
15
-
16
STAT-3 Activates NF-κB in Chronic Lymphocytic Leukemia Cells Dahkki Zhiming Liu, Inbal Hazan‐Halevy, David Harris, Ping Li, Alessandra Ferrajoli, Stefan Faderl, Michael J. Keating, Zeev Estrov
Almmustuhtton 2011Artigo -
17
The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up Dahkki Ravin J. Garg, Hagop M. Kantarjian, Susan O’Brien, Alfonso Quintás‐Cardama, Stefan Faderl, Zeev Estrov, Jorge E. Cortés
Almmustuhtton 2009Artigo -
18
-
19
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells Dahkki Geoffrey Bartholomeusz, Moshe Talpaz, Vaibhav Kapuria, Ling Yuan Kong, Shimei Wang, Zeev Estrov, Waldemar Priebe, Ji Yuan Wu, Nicholas J. Donato
Almmustuhtton 2007Artigo -
20
Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax Dahkki M Lisovsky, Zeev Estrov, X. Zhang, Ugo Consoli, Gisela Sanchez‐Williams, Virginia Snell, Reinhold Munker, A Goodacre, Savchenko Vg, Michael Andreeff
Almmustuhtton 1996Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Leukemia
Oncology
Biology
Myeloid leukemia
Immunology
Gene
Biochemistry
Cancer research
Gastroenterology
Bone marrow
Chemotherapy
Chemistry
Chronic lymphocytic leukemia
Genetics
Surgery
Cell biology
Cancer
Gene expression
Myelodysplastic syndromes
Cytarabine
Receptor
Apoptosis
DNA methylation
Myeloid
Pharmacology
Myelofibrosis
Stem cell
Tyrosine kinase